文献速递主动脉疾病

腹主动脉瘤残留表位自身免疫:弹性蛋白肽初步研究

Remnant Epitope Autoimmunity in Human Abdominal Aortic Aneurysm: A Pilot Study with Elastin Peptides.
PubMed 文献 · Ann Vasc Surg · 2017-06-07

该初步研究假设腹主动脉瘤为炎症触发、以残留血管壁肽段为抗原的自身免疫病,纳入男性腹主动脉瘤患者14例与男性对照8例,检测弹性蛋白特异性T淋巴细胞与IgG。结果显示两组干扰素-γ分泌及抗弹性蛋白IgG滴度均无显著差异,未表明存在明确且恒定的针对残留弹性蛋白肽段的自身免疫过程。

要点

  • 腹主动脉瘤患者与对照的弹性蛋白特异性T细胞反应无显著差异。
  • 两组抗弹性蛋白IgG滴度亦无显著差异。
  • 残留表位驱动的自身免疫假说未获明确支持,需进一步研究。

核心结论

  • 初步研究结果未表明存在明确且恒定的针对残留弹性蛋白肽段的自身免疫过程。

研究设计与样本

  • 初步研究纳入男性腹主动脉瘤患者14例和男性对照8例,分离外周血单核细胞与血浆。
  • 对培养的白细胞进行ELISpot检测弹性蛋白特异性T淋巴细胞,对血浆进行ELISA检测弹性蛋白特异性IgG。

主要发现

  • ELISpot干扰素-γ分泌在腹主动脉瘤组为7.7 ± 9.5%、对照组为4.6 ± 3.5%,差异无统计学意义(P = 0.94)。
  • ELISA抗弹性蛋白IgG滴度在腹主动脉瘤组为77.5 ± 17.8%、对照组为78.2 ± 31.5%,差异无统计学意义(P = 0.55)。
  • 两项结果均表示为相对于各自阳性和阴性对照的百分比。

临床怎么用

  • 该模型可作为进一步研究残留表位驱动腹主动脉瘤病因学的病理生理框架。
  • 当前结果尚不足以支持针对弹性蛋白肽段的自身免疫干预。

局限性

  • 样本量小(腹主动脉瘤14例、对照8例),仅为初步研究。
  • 研究仅纳入男性,结果外推受限。
  • 模型机制及可能抗原仍需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Abdominal aortic aneurysm (AAA) is a prevalent disease affecting around 5% of the population aged more than 65 years. The exact etiology and physiopathology of AAA still raises questions, and elective surgery is currently the only treatment option for this often progressive disease. In this study, we hypothesized and tested a pathophysiological model that depicts AAA as an inflammation-triggered autoimmune disease with remnant vessel wall peptide fragments as the antigen. METHODS: A pilot study with male AAA patients (n = 14) and male controls (n = 8) was conducted. In both study groups, peripheral blood monocytes and plasma were separated from whole blood by centrifugation. An ELISpot test was performed on cultured white blood cells for the presence of elastin-specific T-lymphocytes. An Enzyme-linked immuno sorbent assay (ELISA) was performed on plasma for the presence of elastin-specific IgG molecules. RESULTS: ELISpot interferon-gamma secretion in AAA (7.7 ± 9.5%) and control (4.6 ± 3.5%) and ELISA anti-elastin IgG titer in AAA (77.5 ± 17.8%) and control (78.2 ± 31.5%) were not significantly different (P = 0.94 and P = 0.55, respectively). Both results are expressed as a percentage relative to the respective positive and negative control. CONCLUSIONS: The results of our pilot study did not indicate a clear and invariable autoimmune process directed against remnant elastin peptide fragments. Further research into the model mechanics and a possible antigen is still necessary. In the mean time, the model as presented here already offers a pathophysiological framework to further research into the possible remnant epitope-driven AAA etiology.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Verhoeven J, Lambrecht A, Verbrugghe P, et al. Remnant Epitope Autoimmunity in Human Abdominal Aortic Aneurysm: A Pilot Study with Elastin Peptides. Ann Vasc Surg. 2017. PMID: 28602894. doi:10.1016/j.avsg.2017.05.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。